Collectively, these results confirm that PPM1K mediated-BCKDHA S293 phosphorylation contributed to BCAA metabolic disorder 24 h after cerebral I/R and could be ameliorated by BT2. The gene discussed is BCKDHA; the disease is metabolic disease.